Beijing Strong Biotechnologies,Inc. (300406.SZ)
- Previous Close
13.90 - Open
13.72 - Bid 13.84 x --
- Ask 13.85 x --
- Day's Range
13.72 - 14.02 - 52 Week Range
11.01 - 17.96 - Volume
4,708,440 - Avg. Volume
8,368,507 - Market Cap (intraday)
8.142B - Beta (5Y Monthly) --
- PE Ratio (TTM)
16.67 - EPS (TTM)
0.83 - Earnings Date --
- Forward Dividend & Yield 0.40 (2.88%)
- Ex-Dividend Date May 6, 2025
- 1y Target Est
--
Beijing Strong Biotechnologies,Inc. provides in-vitro diagnostics products and services in the People's Republic of China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein s activity, protein c, lupus anticoagulant, fibrin degradation products, and d-dimer. It also provides blood grouping card comprising ABO blood type anti stereotype detection card, DiaClon ABD-confirmation, and DiaClon ABO/D+ reverse grouping for patients; automatic coagulation analyzer, automatic biochemistry analyzer, and automated blood groupings analyzer; and SARS RBD neutralization antibody, SARS total antibody, SARS COV-2 antigen test kit for self testing, and SARS antigen card. In addition, the company provides technology and document services. It sells its products under the GCELL and Beijing MDC brands. The company was founded in 2001 and is headquartered in Beijing, the People's Republic of China.
www.bsbe.com.cn--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 300406.SZ
View MorePerformance Overview: 300406.SZ
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300406.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300406.SZ
View MoreValuation Measures
Market Cap
8.18B
Enterprise Value
8.30B
Trailing P/E
16.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.23
Price/Book (mrq)
1.94
Enterprise Value/Revenue
5.23
Enterprise Value/EBITDA
13.29
Financial Highlights
Profitability and Income Statement
Profit Margin
31.25%
Return on Assets (ttm)
7.05%
Return on Equity (ttm)
12.28%
Revenue (ttm)
1.58B
Net Income Avi to Common (ttm)
495.24M
Diluted EPS (ttm)
0.83
Balance Sheet and Cash Flow
Total Cash (mrq)
1.06B
Total Debt/Equity (mrq)
27.99%
Levered Free Cash Flow (ttm)
554.65M